• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR RX HERCULINK ELITE STENT SYSTEM; STENT, RENAL Back to Search Results
Catalog Number 1011496-18
Medical Device Problem Codes Off-Label Use (1494); Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/31/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the procedure was to treat a lesion in the celiac artery.The 5.5x18mm herculink elite stent delivery system (sds) was prepared per instructions for use (ifu) and crossed the lesion.Markers were on the catheter and nothing was out of the ordinary.The balloon was inflated and deflated with the stent assumed to have been deployed.However, the stent could not be confirmed via angiogram.The stent could not be found anywhere in the anatomy or in the sheath.The prep table/back table, the floor, the packaging and dispenser hoop were searched and the stent could not be located anywhere.An omnilink stent was implanted without issues to complete the procedure.There was no adverse patient effects and there was no clinically significant delay in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
H6: medical device problem code 1494 - off-label use (incorrect anatomy).Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
A visual inspection was performed on the returned device.The reported stent dislodgement was confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.It was reported that the procedure was to treat a lesion in the celiac artery.It should be noted that the rx herculink elite peripheral stent system instructions for use (ifu), (indications for use) specifies: the rx herculink elite¿ peripheral stent system is indicated for improving arterial luminal diameter in patients with atherosclerotic lesions in renal arteries.It is unknown if the ifu deviation contributed to the reported event.The investigation was unable to determine a conclusive cause for the reported stent dislodgement.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Common Device Name
STENT, RENAL
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key17790045
Report Number2024168-2023-10416
Device Sequence Number7378969
Product Code NIN
UDI-Device Identifier08717648078118
UDI-Public08717648078118
Combination Product (Y/N)N
Initial Reporter StateTN
Initial Reporter CountryUS
PMA/510(K) Number
P110001
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 10/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2026
Device Catalogue Number1011496-18
Device Lot Number3030161
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/09/2023
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/31/2023
Supplement Date Received by Manufacturer09/25/2023
Initial Report FDA Received Date09/21/2023
Supplement Report FDA Received Date10/17/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/01/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age57 YR
Patient SexFemale
Patient Weight57 KG
-
-